{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:23:17Z","timestamp":1785874997561,"version":"3.56.0"},"reference-count":151,"publisher":"Wiley","issue":"9-10","license":[{"start":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T00:00:00Z","timestamp":1637452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Electrophoresis"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A broad range of CE applications from our organization is reviewed to give a flavor of the use of CE within the field of vaccine analyses. Applicability of CE for viral vaccine characterization, and release and stability testing of seasonal influenza virosomal vaccines, universal subunit influenza vaccines, Sabin inactivated polio vaccines (sIPV), and adenovirus vector vaccines were demonstrated. Diverse CZE, CE\u2010SDS, CGE, and cIEF methods were developed, validated, and applied for virus, protein, posttranslational modifications, DNA, and excipient concentration determinations, as well as for the integrity and composition verifications, and identity testing (e.g., CZE for intact virus particles, CE\u2010SDS application for hemagglutinin quantification and influenza strain identification, chloride or bromide determination in process samples). Results were supported by other methods such as RP\u2010HPLC, dynamic light scattering (DLS), and zeta potential measurements. Overall, 16 CE methods are presented that were developed and applied, comprising six adenovirus methods, five viral protein methods, and methods for antibodies determination of glycans, host cell\u2010DNA, excipient chloride, and process impurity bromide. These methods were applied to support in\u2010process control, release, stability, process\u2010 and product characterization and development, and critical reagent testing. Thirteen methods were validated. Intact virus particles were analyzed at concentrations as low as 0.8\u00a0pmol\/L. Overall, CE took viral vaccine testing beyond what was previously possible, improved process and product understanding, and, in total, safety, efficacy, and quality.<\/jats:p>","DOI":"10.1002\/elps.202100269","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T09:10:03Z","timestamp":1636103403000},"page":"1068-1090","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Sixteen capillary electrophoresis applications for viral vaccine analysis"],"prefix":"10.1002","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-6602","authenticated-orcid":false,"given":"Lars","family":"Geurink","sequence":"first","affiliation":[{"name":"Janssen Vaccines and Prevention B.V.  CN Leiden The Netherlands"},{"name":"Department of Medicinal Chemistry Faculty of Pharmacy Biomedical Centre Uppsala University  Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8001-4538","authenticated-orcid":false,"given":"Ewoud","family":"van Tricht","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention B.V.  CN Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3525-4372","authenticated-orcid":false,"given":"Debbie","family":"van der Burg","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention B.V.  CN Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Scheppink","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention B.V.  CN Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojana","family":"Pajic","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention B.V.  CN Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Dudink","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention B.V.  CN Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8409-4443","authenticated-orcid":false,"given":"Cari","family":"S\u00e4nger\u2013van de Griend","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention B.V.  CN Leiden The Netherlands"},{"name":"Department of Medicinal Chemistry Faculty of Pharmacy Biomedical Centre Uppsala University  Uppsala Sweden"},{"name":"Kantisto B.V.  Baarn The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,11,21]]},"reference":[{"key":"e_1_2_9_2_1","volume-title":"WHO Library Cataloguing\u2010in\u2010Publication Data","author":"World Health Organization (WHO)","year":"2013"},{"key":"e_1_2_9_3_1","volume-title":"ICH guideline Q8 (R2) on pharmaceutical development: Step 5","author":"European Medicines Agency (EMA)","year":"2017"},{"key":"e_1_2_9_4_1","volume-title":"Process Validation: General Principles and Practices","author":"U.S. Food and Drug Administration (USFDA)","year":"2011"},{"key":"e_1_2_9_5_1","volume-title":"ICH note for guidance on validation of analytical procedures: text and methodology","author":"European Medicines Agency (EMA)","year":"1995"},{"key":"e_1_2_9_6_1","volume-title":"PDA Technical Report No. 60\u20133 (TR 60\u20133) Process Validation: A Lifecycle Approach, Annex 2: Biopharmaceutical Drug Substances Manufacturing","author":"Parenteral Drug Association (PDA)"},{"key":"e_1_2_9_7_1","volume-title":"Guideline on process validation for finished products \u2010 information and data to be provided in regulatory submissions","author":"European Medicines Agency (EMA)","year":"2016"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9598-3"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2016.06.004"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-9936(01)00112-1"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.200700397"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac049842x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac034898x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac048999m"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.200600066"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac990503r"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac981324x"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac00214a011"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(00)96340-4"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2017.01.013"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201900068"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(00)00755-X"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201000274"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2008.09.049"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2010.12.032"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2012.05.015"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2012.07.033"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2012.08.029"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(97)00334-4"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)00219-X"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac9603789"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.200600211"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.200305622"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2015.07.047"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.202000107"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2015.03.021"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201500186"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2016.04.025"},{"key":"e_1_2_9_39_1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-62703-327-5_11","volume-title":"Glycosylation Engineering of Biopharmaceuticals: Methods and Protocols","author":"Rustandi R. R.","year":"2013"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201200095"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201300422"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1006\/abio.2000.4651"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201500054"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(99)01045-6"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2020.233"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2014.05.004"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-2670(98)00715-6"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(02)01391-2"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(96)01922-X"},{"key":"e_1_2_9_50_1","volume-title":"IgG Purity and Heterogeneity Assay Kit: Application guide","author":"AB\u2010Sciex","year":"2018"},{"key":"e_1_2_9_51_1","volume-title":"DNA Extractor \u24c7 Kit instructions","author":"FUJIFILM Wako Chemicals U.S.A. Corporation"},{"key":"e_1_2_9_52_1","volume-title":"dsDNA 1000 Kit: Application guide","author":"AB\u2010Sciex","year":"2020"},{"key":"e_1_2_9_53_1","volume-title":"ChemiDoc and ChemiDoc MP Imaging Systems with Image Lab Touch Software: User Guide","author":"Bio\u2010rad Laboratories, i.","year":"2020"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2018.10.045"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2017.1368602"},{"key":"e_1_2_9_56_1","volume-title":"Guideline on bioanalytical method validation","author":"European Medicines Agency (EMA)","year":"2011"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2019.05.014"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-017-0447-x"},{"key":"e_1_2_9_59_1","author":"Leach M. N. E.","year":"2018","journal-title":"CASSS"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2017.07.047"},{"key":"e_1_2_9_61_1","volume-title":"Purity Analysis of Adeno\u2010Associated Virus (AAV) Capsid Proteins using CE\u2010SDS Method","author":"Li T.","year":"2019"},{"key":"e_1_2_9_62_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-4939-9213-3_19","volume-title":"Clinical Applications of Capillary Electrophoresis: Methods and Protocols","author":"Zhang C.","year":"2019"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-18"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.69.1.531"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008495"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.3.1239-1246.1989"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/13484"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac7263"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02350"},{"key":"e_1_2_9_70_1","unstructured":"Impagliazzo A. Meijberg J. W. Radosevic K. Wagner M. Ding Z. US patent: US10117925B22015."},{"key":"e_1_2_9_71_1","author":"Milder F. J.","year":"2019","journal-title":"European patent: EP18152991"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(02)00821-3"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.139.3.613"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2019.113006"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.202100068"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2015.04.024"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/mas.21629"},{"key":"e_1_2_9_78_1","volume-title":"Fast Glycan Labeling and Analysis Kit: Application guide","author":"AB\u2010Sciex","year":"2020"},{"key":"e_1_2_9_79_1","volume-title":"GlycanAssure\u2122 HyPerformance APTS Kit: User guide","author":"Scientific T. F.","year":"2018"},{"key":"e_1_2_9_80_1","volume-title":"Beckman Coulter Capillary Isoelectric Focusing (cIEF) Analysis: Application guide","author":"AB\u2010Sciex","year":"2014"},{"key":"e_1_2_9_81_1","volume-title":"User Guide for Maurice, Maurice C. and Maurice S.","author":"ProteinSimple"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.200500889"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2018.12.021"},{"key":"e_1_2_9_84_1","volume-title":"Rapid and reproducible high\u2010resolution charge variant analysis of adalimumab (mAb) using the IntaBio Imaged CIEF\u2010MS System","author":"Chen W."},{"key":"e_1_2_9_85_1","volume-title":"Rapid, comprehensive, high resolution charge variant characterization using the IntaBio iCIEF\u2010MS System with SCIEX TripleTOF 6600+ and Protein Metrics Byos Software","author":"Chen W."},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2019.113785"},{"key":"e_1_2_9_87_1","first-page":"544","volume":"221","author":"Crawt L.","year":"2019","journal-title":"J. Infect. Dis."},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-67-7-1283"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2010.07.037"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00356-x"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30476-X"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.537498"},{"key":"e_1_2_9_93_1","unstructured":"Luitjens A. vanHerk H. US patent: US2012031.5696A12012."},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1021\/bp070258u"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1021\/bp034237l"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/bit.20406"},{"key":"e_1_2_9_97_1","unstructured":"Luitjens A. Lewis J. A. US patent: US10041049B22018."},{"key":"e_1_2_9_98_1","unstructured":"Vogels R. Bout A. US patent: US7468181B22008."},{"key":"e_1_2_9_99_1","unstructured":"Vogels R. Havenga M. Mehtali M. US patent: US6492169B12002."},{"key":"e_1_2_9_100_1","unstructured":"Weggeman M. US patent: US6485958B22002."},{"key":"e_1_2_9_101_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-36-1-59"},{"key":"e_1_2_9_102_1","unstructured":"Imler J.\u2010L. Mehtali M. Pavirani A. US patent: US6040174A2000."},{"key":"e_1_2_9_103_1","unstructured":"Massie B. US patent: US5891690A1999."},{"key":"e_1_2_9_104_1","unstructured":"Kovesdi I. Brough D.E. McVeyD.L. BruderJ.T. Lizonova A. US patent: US5851806A1998."},{"key":"e_1_2_9_105_1","unstructured":"Weggeman M. US patent: US67006405P2013."},{"key":"e_1_2_9_106_1","unstructured":"Weggeman M. vanCorven E. J. J. M. US patent: US8124106B22012."},{"key":"e_1_2_9_107_1","unstructured":"Konz J. O.Jr. Lee A. L. To C. S. B. Goerke A. R. US patent: US7326555B22008."},{"key":"e_1_2_9_108_1","unstructured":"Carri\u00f3n M. E. Menger M. Kovesdi I. US patent: US6586226B22003."},{"key":"e_1_2_9_109_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1997.8.4-453"},{"key":"e_1_2_9_110_1","unstructured":"Tang J. C.\u2010T. Vellekamp G. Bondoc L. L.Jr. US patent: US6261823B12001."},{"key":"e_1_2_9_111_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20157"},{"key":"e_1_2_9_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/10_008"},{"key":"e_1_2_9_113_1","unstructured":"Evans R. K.Volken D. B. Isopi L. A. US patent: US7456009B22008."},{"key":"e_1_2_9_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301527"},{"key":"e_1_2_9_115_1","unstructured":"Adriaansen J. US patent: US9974737B22018."},{"key":"e_1_2_9_116_1","unstructured":"Adriaansen J. US patent: US20160199426A12016."},{"key":"e_1_2_9_117_1","doi-asserted-by":"publisher","DOI":"10.12665\/J11.Sosnowski"},{"key":"e_1_2_9_118_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac201006u"},{"key":"e_1_2_9_119_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac302525y"},{"key":"e_1_2_9_120_1","volume-title":"Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications","author":"U.S. Food and Drug Administration (USFDA)","year":"2010"},{"key":"e_1_2_9_121_1","volume-title":"European Pharmacopoeia, 5.2.3, ID: 01\/2018:50203","author":"European Directorate for the Quality of Medicines & HealthCare (EDQM)","year":"2020"},{"key":"e_1_2_9_122_1","volume-title":"European pharmacopoeia, 5.14, ID: 01\/2018:50203","author":"European Directorate for the Quality of Medicines & HealthCare (EDQM)","year":"2020"},{"key":"e_1_2_9_123_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1998.9.13-1909"},{"key":"e_1_2_9_124_1","unstructured":"U.S. Food and Drug Administration (USFDA) NTIS Issue Number 2013042012."},{"key":"e_1_2_9_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2009.02.015"},{"key":"e_1_2_9_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2009.04.002"},{"key":"e_1_2_9_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.145"},{"key":"e_1_2_9_128_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23546"},{"key":"e_1_2_9_129_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01453-15"},{"key":"e_1_2_9_130_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.19.2.685-708.1976"},{"key":"e_1_2_9_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(74)90336-5"},{"key":"e_1_2_9_132_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21008"},{"key":"e_1_2_9_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2006.11.031"},{"key":"e_1_2_9_134_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302071"},{"key":"e_1_2_9_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(68)90121-9"},{"key":"e_1_2_9_136_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2002.1406"},{"key":"e_1_2_9_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05580-5"},{"key":"e_1_2_9_138_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10382"},{"key":"e_1_2_9_139_1","doi-asserted-by":"publisher","DOI":"10.1086\/339073"},{"key":"e_1_2_9_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-0934(01)00257-9"},{"key":"e_1_2_9_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2017.07.046"},{"key":"e_1_2_9_142_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201500431"},{"key":"e_1_2_9_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-019-02102-8"},{"key":"e_1_2_9_144_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201600464"},{"key":"e_1_2_9_145_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.202000180"},{"key":"e_1_2_9_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114089"},{"key":"e_1_2_9_147_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.7b04608"},{"key":"e_1_2_9_148_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201900325"},{"key":"e_1_2_9_149_1","doi-asserted-by":"publisher","DOI":"10.1021\/la404884a"},{"key":"e_1_2_9_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2007.10.114"},{"key":"e_1_2_9_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(99)01207-8"},{"key":"e_1_2_9_152_1","volume-title":"Human adenovirus 5 VR\u20101516: product sheet","author":"American Type Culture Collection (ATTC)"}],"container-title":["ELECTROPHORESIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/elps.202100269","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/elps.202100269","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/elps.202100269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:01:18Z","timestamp":1760526078000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/elps.202100269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,21]]},"references-count":151,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1002\/elps.202100269"],"URL":"https:\/\/doi.org\/10.1002\/elps.202100269","archive":["Portico"],"relation":{},"ISSN":["0173-0835","1522-2683"],"issn-type":[{"value":"0173-0835","type":"print"},{"value":"1522-2683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,21]]},"assertion":[{"value":"2021-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}